Related Experiment Video
Updated: Jan 26, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus
Jung Wan Park1,2, Hyungmin Lee1, Jung Wook Kim3
1Department of Healthcare-Associated Infection Control, Korea Centers for Disease Control and Prevention, Cheongju, South Korea.
Abstract:
The aim of the present study was to describe the characteristics of infections with Staphylococcus aureus with reduced vancomycin susceptibility (SARVS) including vancomycin-intermediate S. aureus (VISA) in South Korea, using data from the national sentinel surveillance system during 2014-2016. A total of 66 patients infected or colonized with SA-RVS were reported using the sentinel surveillance system. Among them, VISA was confirmed in 14 isolates (21.2%) and no vancomycin-resistant S. aureus (VRSA) was detected. Most of patients had any kind of indwelling devices (81.8%, 54/66) and underwent surgical procedures in the previous 6 months (84.8%, 56/66). Patients who admitted to an intensive care unit (ICU) in the previous 3 months were 68.2% (45/66). Furthermore, patients who used vancomycin or had MRSA in the previous 1 month were 54.5% (36/66) and 59.1% (39/66), respectively. Upon review of the medical records, 54.5% (36/66) of patients were classified as having SA-RVSassociated infection and 30-day mortality was 19.4% (7/36). Our findings revealed that there was no VRSA in South Korea. SA-RVS including VISA existed particularly in patients who had indwelling devices, history of surgical procedure, and history of ICU admission.
Insights
Staphylococcus aureus with reduced vancomycin susceptibility (SARVS), including vancomycin-intermediate S. aureus (VISA), was found in South Korea. No vancomycin-resistant S. aureus (VRSA) was detected, with SARVS linked to indwelling devices and prior procedures.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health Surveillance
Background:
- Antimicrobial resistance is a growing global health concern.
- Staphylococcus aureus, particularly methicillin-resistant strains, poses a significant threat.
- Monitoring reduced susceptibility to last-resort antibiotics like vancomycin is crucial.
Purpose of the Study:
- To characterize infections caused by Staphylococcus aureus with reduced vancomycin susceptibility (SARVS) in South Korea.
- To identify the prevalence of vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA).
- To determine risk factors associated with SARVS infections.
Main Methods:
- Analysis of data from a national sentinel surveillance system (2014-2016).
- Identification and susceptibility testing of Staphylococcus aureus isolates.
- Review of medical records for patient demographics and clinical history.
Main Results:
- 66 cases of SA-RVS were reported; 14 isolates (21.2%) were VISA.
- No vancomycin-resistant S. aureus (VRSA) was detected.
- SA-RVS was associated with indwelling devices (81.8%), recent surgery (84.8%), ICU admission (68.2%), and prior vancomycin or MRSA exposure.
Conclusions:
- SA-RVS, including VISA, is present in South Korea, primarily in high-risk patients.
- The absence of VRSA is a positive finding, but continued surveillance is essential.
- Risk factors highlight the need for infection control measures in vulnerable patient populations.
Related Concept Videos
Disassembly of Intermediate Filaments
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
Types of Intermediate Filaments
Formation of Intermediate Filaments
The Structure of Intermediate Filaments
Intermediate...
Elevation of Intermediate Points on Vertical Curves
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...

